GATAD2B and Neurodevelopmental delay: Recently, mutations in GATAD2B were identified in patients with GAND (GATAD2B-associated neurodevelopmental disorder), a NDD characterized by intellectual disability (ID), infantile hypotonia, apraxia of speech, epilepsy.